| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +85.71% | +17.94% | +0.15% | +17.78% | +11.97% | — |
| 14d | 7 | +71.43% | +32.98% | +0.08% | +32.89% | +37.07% | — |
| 30d | 7 | +71.43% | +46.19% | -0.67% | +46.86% | +39.35% | — |
| 60d | 7 | +42.86% | +5.54% | +0.64% | +4.91% | -1.97% | — |
| 90d | 7 | +71.43% | +32.12% | +2.20% | +29.92% | +42.43% | — |
| 180d | 7 | +0.00% | -39.93% | +3.37% | -43.30% | -42.34% | — |
| 1y | 7(6 pending) | +0.00% | -9.02% | +12.15% | -21.18% | -21.18% | — |
| 2y | 7(7 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AARD AARDVARK THERAPEUTICS, INC. | SALEGRANT Stock grant | 203,851 | — | — | 203,851 | Feb 9, 2026 | Feb 11, 2026 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 7,000 | $14.49 | $101.4K | 1,551,613 | Dec 11, 2025 | Dec 12, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,229 | — | — | 40,566 | Oct 15, 2025 | Oct 16, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 1,229 | $4.24 | $5.2K | 1,544,613 | Oct 15, 2025 | Oct 16, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 6,500 | $9.51 | $61.8K | 1,539,884 | Sep 15, 2025 | Sep 16, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 3,500 | $9.94 | $34.8K | 1,543,384 | Sep 15, 2025 | Sep 16, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 5,000 | $8.50 | $42.5K | 1,533,384 | Sep 12, 2025 | Sep 12, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 6,000 | $7.82 | $46.9K | 1,528,384 | Sep 11, 2025 | Sep 12, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 9,000 | $7.91 | $71.2K | 1,522,384 | Sep 10, 2025 | Sep 12, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 17,209 | $4.24 | $73.0K | 1,513,384 | Aug 28, 2025 | Aug 29, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | SALE Chief Executive Officer | 17,209 | — | — | 41,795 | Aug 28, 2025 | Aug 29, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 549,534 | — | — | 549,534 | Jun 11, 2025 | Jun 13, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | SALE Chief Executive Officer | 350,002 | — | — | 0 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 41,303 | — | — | 1,479,633 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| AARD AARDVARK THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 16,542 | $16.00 | $264.7K | 1,496,175 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| SCLX SCILEX HOLDING CO | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Jan 17, 2023 | Jan 17, 2023 ↗ | View → |